Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

James E Wagner Cultivation Corp JWCAF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
James E. Wagner Cultivation Corp, through its subsidiary is a licensed producer of medical cannabis focusing on producing clean, consistent cannabis using an advanced and proprietary aeroponic platform named GrowthSTORM. The company's operations are based in Kitchener, Ontario.


GREY:JWCAF - Post by User

James E Wagner Cultivation Corp > Initial Closing of its up to $7,500,000 Private Placement
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by The6Kidon Dec 20, 2019 9:52am
45 Views
Post# 30476273

RE:RE:RE:RE:RE:RE:Initial Closing of its up to $7,500,000 Private Placement

RE:RE:RE:RE:RE:RE:Initial Closing of its up to $7,500,000 Private PlacementI just really don't like how on the Q3 conference call the CEO kept mentioning how they won't need to dilute then within the next 4 months they do a $4M dilutive deal with Trichrome then this $7.5M private placement at ATL's

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities